Is the price fair?
What CRVS's price assumes
- Price / book
- 5.47
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 5.47
- Market capitalisation
- $1.00B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
Ranks #104 of 145 by Smart Score